Developmental and environmental origins of breast cancer: DDT as a case study

Reproductive Toxicology

Volumn 31, Issue 3, 2011, Pages 302-311

  Cohn, Barbara A ^a  

^a PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

Birth cohort; Breast cancer; Children; Chronic disease; Cohort; Commentary; DDE; DDT; Developmental origins of health and disease; Environment; Longitudinal study; Pregnancy; Press; Puberty

Indexed keywords

CHLORPHENOTANE;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; CASE STUDY; CAUSAL ATTRIBUTION; CONCENTRATION (PARAMETERS); EARLY LIFE STRESS; ENVIRONMENTAL EXPOSURE; FEASIBILITY STUDY; HUMAN; LONGITUDINAL STUDY; NONHUMAN; PERINATAL PERIOD; PREDICTION; PREGNANCY OUTCOME; REPRODUCTIVE HEALTH;

ADULT; BREAST NEOPLASMS; CARCINOGENS, ENVIRONMENTAL; DDT; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 79953758318     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.10.004     Document Type: Article

References (92)

1. MacMahon B., Cole P., Lin T.M., Lowe C.R., Mirra A.P., Ravnihar B., et al. Age at first birth and breast cancer risk. Bull World Health Organ 1970, 43:209-221.
2. Kelsey J.L., Gammon M.D., John E.M. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47.
3. Colditz G.A., Baer H.J., Tamimi R.M. Breast cancer. Cancer epidemiology and prevention 2006, 995-1012. Oxford University Press, New York. 3rd ed. D. Schottenfeld, J.F. Fraumeni (Eds.).
4. Silva I.D., Stavola B.D., McCormack V. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med 2008, 5:e193.
5. Michels K.B., Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer 2006, 119:2007-2025.
6. Xue F., Michels K.B. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 2007, 8:1088-1100.
7. Palmer J.R., Wise L.A., Hatch E.E., Troisi R., Titus-Ernstoff L., Strohsnitter W., et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:1509-1514.
8. Innes K.E., Byers T.E. Preeclampsia and breast cancer. Epidemiology 1999, 10:722-732.
9. Troisi R., Potischman N., Hoover R.N. Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 2007, 16:1700-1712.
10. Perry J.K., Mohankumar K.M., Emerald B.S., Mertani H.C., Lobie P.E. The contribution of growth hormone to mammary neoplasia. J Mammary Gland Biol Neoplasia 2008, 13:131-145.
11. Ruder E.H., Dorgan J.F., Kranz S., Kris-Etherton P.M., Hartman T.J. Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer 2008, 8:334-342.
12. Siiteri P.K., MacDonald P.C. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol 1966, 26:751-761.
13. Russo J., Tay L.K., Russo I.H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982, 2:5-73.
14. Cavalieri E.L., Rogan E.G. A unified mechanism in the initiation of cancer. Ann NY Acad Sci 2002, 959:341-354.
15. Siiteri P.K., Simberg N., Murai J. Estrogens and breast cancer. Ann NY Acad Sci 1986, 464:100-105.
16. Nechuta S., Paneth N., Velie E.M. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 2010.
17. Cohn B.A., Cirillo P.M., Christianson R.E., van den Berg B.J., Siiteri P.K. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 2001, 93:1133-1140.
18. Cnattingius S., Torrang A., Ekbom A., Granath F., Petersson G., Lambe M. Pregnancy characteristics and maternal risk of breast cancer. JAMA 2005, 294:2474-2480. %R 101001/jama294192474.
19. Innes K., Byers T. Preeclampsia and breast cancer risk. Epidemiology 1999, 10:722-732.
20. Richardson B.E., Peck J.D., Wormuth J.K. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000, 9:1349-1355.
21. Olsen J., Storm H. Pregnancy experience in women who later developed oestrogen-related cancers (Denmark). Cancer Causes Control 1998, 9:653-657.
22. Hoover R.N., Troisi R.J. Understanding mechanisms of breast cancer prevention. J Natl Cancer Inst 2001, 93:1119-1120.
23. Lambe M., Hsieh C.C., Trichopoulos D., Ekbom A., Pavia M., Adami H.O. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994, 331:5-9.
24. Wolff M.S., Engel S., Berkowitz G., Teitelbaum S., Siskind J., Barr D.B., et al. Prenatal pesticide and PCB exposures and birth outcomes. Pediatr Res 2007, 61:243-250.
25. Longnecker M., Klebanoff M., Zhou H., Brock J. Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth. The Lancet 2001, 358:110-114.
26. Siddiqui M.K., Nigam U., Srivastava S., Tejeshwar D.S., Chandrawati Association of maternal blood pressure and hemoglobin level with organochlorines in human milk. Hum Exp Toxicol 2002, 21:1-6.
27. Osuch J.R., Karmaus W., Hoekman P., Mudd L., Zhang J., Haan P., et al. Association of age at menarche with adult leg length and trunk height: speculations in relation to breast cancer risk. Ann Human Biol 2010, 37:76-85.
28. Gluckman P.D., Hanson M.A. Evolution, development and timing of puberty. Trends Endocrinol Metab 2006, 17:7-12.
29. Ronckers C.M., Erdmann C.A., Land C.E. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005, 7:21-32.
30. Tokunaga M., Land C., Tokuoka S., Nishimori I., Soda M., Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994, 138:209-223.
31. Fenton S.E. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 2006, 147:s18-s24.
32. Calle E.E., Frumkin H., Henley S.J., Savitz D.A., Thun M.J., Organochlorines Breast cancer risk. CA Cancer J Clin 2002, 52:301-309.
33. Cohn B.A., Wolff M.S., Cirillo P.M., Sholtz R.I. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect 2007, 115:1406-1414.
34. Laden F., Collman G., Iwamoto K., Alberg A.J., Berkowitz G.S., Freudenheim J.L., et al. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 2001, 93:768-776.
35. Morgan D., Roan C.C. The metabolism of DDT in man. Essays in toxicology 1975, 39-97. Academic Press, New York and London. W.J. Hayes (Ed.).
36. U.S.Environmental Protection Agency DDT, a review of scientific and economic aspects of the decision to ban its use as a pesticide 1975, United States Environmental Protection Agency, Washington, DC.
37. Kutz F.W., Wood P.H., Bottimore D.P. Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Rev Environ Contam Toxicol 1991, 120:1-82.
38. Agency for Toxic Substances and Disease Registry Toxicological profile for DDT, DDE, and DDD 2002, U.S. Department of Health and Human Services, Public Health Service.
39. Kitamura S., Shimizu Y., Shiraga Y., Yoshida M., Sugihara K., Ohta S. Reductive metabolism of p,p'-DDT and o,p'-DDT by rat liver cytochrome P450. Drug Metab Dispos 2002, 30:113-118.
40. Stehr-Green P.A. Demographic and seasonal influences on human serum pesticide residue levels. J Toxicol Environ Health 1989, 27:405-421.
41. Longnecker M.P., Rogan W.J., Lucier G. The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health 1997, 18:211-244.
42. Kelce W.R., Stone C.R., Laws S.C., Gray L.E., Kemppainen J.A., Wilson E.M. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 1995, 375:581-585.
43. Perry M.J., Ouyang F., Korrick S., Venners S.A., Altshul L., Xu X., et al. Body mass index and serum 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane in nulliparous chinese women. Cancer Epidemiol Biomarkers Prev 2005, 14:2433-2438.
44. Wolff M.S., Britton J.A., Teitelbaum S.L., Eng S., Deych E., Ireland K., et al. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 2005, 14:2224-2236.
45. Wolff M.S., Anderson H.A. Polybrominated biphenyls: sources and disposition of exposure among Michigan farm residents, 1976-1980. Eur J Oncol 1999, 4:645-651.
46. Cohn B.A., Cirillo P.M., Wolff M.S., Schwingl P.J., Cohen R.D., Sholtz R.I., et al. DDT and DDE exposure in mothers and time to pregnancy in daughters. Lancet 2003, 361:2205-2206.
47. Cohn B.A., Cirillo P.M., Christianson R.E. Prenatal DDT exposure and testicular cancer: a nested case-control study. Arch Occup Environ Health 2010, 65:127-134.
48. Eskenazi B., Chevrier J., Rosas L.G., Anderson H.A., Bornman M.S., Bouwman H., et al. The Pine River statement: human health consequences of DDT use. Environ Health Perspect 2009, 117:1359-1367.
49. van den Berg B.J. The California child health and development studies. Handbook of longitudinal research 1984, vol. 1:166-179. Praeger, New York.
50. Yamasaki H., Loktionov A., Tomatis L. Perinatal and multigenerational effect of carcinogens: possible contribution to determination of cancer susceptibility. Environ Health Perspect 1992, 98:39-43.
51. Kolata G. What causes cancer: can science find the missing link? 2002, New York Times, New York, p 1. late edition ed.
52. Kolata G. Looking for the link 2002, NY Times (Print).
53. Gammon M.D., Wolff M.S., Neugut A.I., Eng S.M., Teitelbaum S.L., Britton J.A., et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 2002, 11:686-697.
54. Hunter D.J., Hankinson S.E., Laden F., Colditz G.A., Manson J.E., Willett W.C., et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997, 337:1259-1268.
55. vom Saal F.S., Welshons W.V., Hansen L.G., Talbott E.O., Zborowski J.V., Kuller L.H., et al. Organochlorine residues and breast cancer. N Engl J Med 1998, 338:988-991.
56. Hardy J.B. The collaborative perinatal project: lessons and legacy. Ann Epidemiol 2003, 13:303-311.
57. Gluckman P.D., Hanson M.A., Beedle A.S. Non-genomic transgenerational inheritance of disease risk. BioEssays 2007, 29:145-147.
58. Anway M.D., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 2006, 147:s43-s49.
59. Steinberg R.M., Walker D.M., Juenger T.E., Woller M.J., Gore A.C. Effects of perinatal polychlorinated biphenyls on adult female rat reproduction: development, reproductive physiology, and second generational effects. Biol Reprod 2008, 78:1091-1101.
60. Janine F., Felix J.F., Steegers-Theunissen R.P., de Walle H.E., de Klein A., Torfs C.P., et al. Esophageal atresia and tracheoesophageal fistula in children of women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol 2007, 197:38.e1-38.e5.
61. Udry J.R, Morris N.M., Kovenock J. Androgen effects on women's gendered behaviour. J Biosoc Sci 1995, 27:359-368.
62. Campbell B.C., Udry J.R. Stress and age of menarche in mothers and daughters. J Biosoc Sci 1995, 127:127-134.
63. Kandel D.B., Udry J.R. Prenatal effects of maternal smoking on daughters' smoking: nicotine or testosterone exposure?. Am J Public Health 1999, 89:1377-1383.
64. Udry J.R. Biological limits of gender construction. Am Sociol Rev 2000, 65:443-457.
65. Susser E., Schaefer C., Brown A., Begg M., Jed Wyatt R. The design of the prenatal determinants of schizophrenia study (PDS). Schizophr Bull 2000, 26:257-273.
66. Bresnahan M.A., Brown A.S., Schaefer C.A., Begg M.D., Wyatt R.J., Susser E.S. Incidence and cumulative risk of treated schizophrenia in the prenatal determinants of schizophrenia study. Schizophr Bull 2000, 26:297-298.
67. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004, 61:774-780.
68. Brown A.S., Bottiglieri T., Schaefer C.A., Quesenberry C.P., Liu L., Bresnahan M., et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 2007, 64:31-39.
69. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004, 161:889-895.
70. Brown A.S., Schaefer C.A., Quesenberry C.P., Liu L., Babulas V.P., Susser E.S. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005, 162:767-773.
71. Brown A.S., Schaefer C.A., Quesenberry C.P., Shen L., Susser E.S. No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia?. Am J Psychiatry 2006, 163:2178-2180.
72. Brown A.S., Schaefer C.A., Wyatt R.J., Begg M.D., Goetz R., Bresnahan M.A., et al. Paternal age and risk of schizophrenia in adult offspring. Am J Psychiatry 2002, 159:1528-1533.
73. Brown A.S., Susser E.S., Homocysteine, schizophrenia: From prenatal to adult life. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1175-1180.
74. Lyerly A.D., Little M.O., Faden R.R. The national children's study: a golden opportunity to advance the health of pregnant women. Am J Public Health 2009, 99:1742-1745.
75. Kaiser J. EPIDEMIOLOGY: children's study needs pilot testing, panel finds. Science 2008, 320:1147.
76. Medicine NRCaIo The national children's study research plan: a review. panel to review the national children's study research plan. Committee on national statistics, division of behavioral and social sciences and education 2008, Board on Children, Youth, and Families and Board on Population Health and Public Health Practice, Institute of Medicine, Washington, DC.
77. Symonds M.E., Sebert S.P., Hyatt M.A., Budge H. Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol 2009, 5:604-610.
78. McMillen I.C., Rattanatray L., Duffield J.A., Morrison J.L., MacLaughlin S.M., Gentili S., et al. The early origins of later obesity: pathways and mechanisms. Early nutrition programming and health outcomes in later life 2009, 71-81. Springer, Netherlands. B. Koletzko, T. Decsi, D. Molnár, A. Hunty (Eds.).
79. Ward E., Schulte P., Grajewski B., Andersen A., Patterson D.J., Turner W., et al. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomarkers Prev 2000, 9:1357-1367.
80. Helzlsouer K., Alberg A., Huang H., Hoffman S., Strickland P., Brock J., et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 1999, 8:525-532.
81. Hoyer A.P., Grandjean P., Jorgensen T., Brock J.W., Hartvig H.B. Organochlorine exposure and risk of breast cancer. Lancet 1998, 352:1816-1820.
82. Hoyer A.P., Torben J., Grandjean P., Helle B.H. Repeated measurements of organochlorine expsorues and breast cancer risk (Denmark). Cancer Causes Control 2000, 11:177-184.
83. Dorgan J., Brock J., Rothman N., Needham L., Miller R., Stephenson H.J., et al. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 1999, 10:1-11.
84. Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 2000, 9:271-277.
85. Moysich K., Ambrosone C., Vena J., Shields P., Mendola P., Kostyniak P., et al. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998, 7:181-188.
86. Wolff M.S., Berkowitz G.S., Brower S., Senie R., Bleiweiss I.J., Tartter P., et al. Organochlorine exposures and breast cancer risk in New York City women. Environ Res 2000, 84:151-161.
87. Millikan R., DeVoto E., Duell E., Tse C., Savitz D., Beach J., et al. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 2000, 9:1233-1240.
88. Demers A., Ayotte P., Brisson J., Dodin S., Robert J., Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev 2000, 9:161-166.
89. Zheng T., Holford T., Mayne S., Tessari J., Ward B., Carter D., et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 2000, 9:167-174.
90. Krieger N., Wolff M.S., Hiatt R.A., Rivera M., Vogelman J., Orentreich N. Breast cancer and serum organochlorines: a prospective study among White, Black, and Asian women. J Natl Cancer Inst 1994, 86:589-599.
91. Lopez-Carillo L., Blair A., Lopez-Cervantes M., Cebrian M., Rueda C., Reyes R., et al. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case control study from Mexico. Cancer Res 1997, 57:3728-3732.
92. Romieu I., Hernandez-Avila M., Lazcano-Ponce E., Weber J.P., Dewailly E. Breast cancer, lactation history and serum organochlorines. Am J Epidemiol 2000, 152:363-370.